In a now famous, decade old interview with Fortune magazine, self-styled "Worldwide Wing Commander" of Hooters restaurants Robert Brooks said, "Good food, cold beer and pretty girls never go out of style." With more than 430 locations generating close to $1B revenues, 30 years after the first Hooters restaurant opened in Florida, Brooks' statement looks vindicated. Throughout the majority of this growth however, the retail investment community has been unable to gain exposure to the world famous brand. One company now offers this exposure-Chanticleer Holdings (HOTR).
Chanticleer is a publicly-traded holding company that not only has a small, 3% stake in Hooters of America, the privately-owned parent company of the Hooters brand, but is also a franchisee of domestic and international Hooters locations. The company is in the early stages of a rapid expansionary strategy that its CEO, Mike Pruitt, expects to make Chanticleer profitable before the end of the year.
International Revenues Comparison
Chanticleer's profitability lies in international expansion of the Hooters brand. The international market remains relatively untapped, yet has proven key to a number of other U.S. fast casual establishments in the past. Yum! Brands (YUM), owner of the KFC, Taco Bell and Pizza Hut fast-food chains, generated approximately 25% of its total revenues from international operations last year. McDonald's Corporation (MCD) generated just shy of 70% of its revenues internationally during 2012. Burger King Worldwide (BKW) generated 42% of its revenues during the first three quarters of 2013 from international locations. Of 430 hooters locations, 58 are located outside of the U.S. With average sales per location (FY 2012) of $2.26M, Hooters generates just 19% of its revenues from international locations on estimated system wide sales (FY 2012) of 971.8M.
Recent SONN News
- Sonnet BioTherapeutics Announces Exercise of Warrants for $3.4 Million in Gross Proceeds • GlobeNewswire Inc. • 06/20/2024 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/13/2024 12:15:34 PM
- Sonnet BioTherapeutics Announces the Generation and Characterization of Two Novel Immunotherapeutic Pipeline Drug Candidates, SON-1411 and SON-1400, Each Containing a Variant IL-18 Domain • GlobeNewswire Inc. • 06/13/2024 12:00:00 PM
- Sonnet BioTherapeutics to Present SB221 as a Trial in Progress at the ASCO 2024 Annual Meeting • GlobeNewswire Inc. • 05/28/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/22/2024 11:35:12 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/20/2024 01:25:20 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 05/17/2024 04:15:34 AM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 05/16/2024 08:16:44 PM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 05/15/2024 08:06:12 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/14/2024 09:25:32 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/14/2024 09:07:54 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/14/2024 08:26:32 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/11/2024 11:30:24 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/14/2024 12:35:22 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/14/2024 12:30:31 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/01/2024 09:20:34 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/29/2024 09:15:16 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 01/02/2024 09:19:28 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/27/2023 09:56:04 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 12/22/2023 09:31:11 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/15/2023 09:30:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/14/2023 10:03:39 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 12/14/2023 10:02:10 PM
FEATURED Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM